Let's Talk Health Care

Stents Vs. Bypass - Again

Email This Post Email This Post      Print This Post Print This Post

A new study - a big one ($50 MM) - was recently released that compared the short and long term effects of drug eluding stents to bypass surgery for patients with serious heart disease.  The headlines - “Heart Surgery Bests Stents” - pretty much told the story.  In this particular case, 18% of those patients who had stents installed to treat their disease ended up either dying or needing another treatment over the next twelve months.  Only 12% of bypass patients ended up with complications or passing on.  The death rate in both instances was the same - 8%.

Stents - the tool of choice for interventional cardiologists - and bypass surgery - the technique of choice for cardiothoracic surgeons - have been playing this “which is better” game for almost ten years.  Needless to say, both sides were represented in the stories that ran covering the results of this study.  The bypass surgeons said, “More people should have bypass surgery instead of stents.”  The stent docs said this study proved that stenting - which involves a much less aggressive and invasive procedure than bypass surgery - comes in a close second to bypass surgery, even in patients with complex conditions.

And if one chooses to read the comments underneath these articles at various online news sources, it’s pretty clear that both sides are doing the best they can to make their case, based on these results.  To use a stupid sports analogy, it’s a lot like watching Federer and Nadal hit tennis balls at one another.

But what’s really interesting to me about all this is not one article - and not one comment - says anything about the cost of either procedure.  For what it’s worth, stent procedures cost about a third of what bypass surgery costs - $20,000 vs. $60,000.  These numbers can and do vary with every case - and may cost more or less based on the patient’s condition, where the service is delivered, and what part of the country you’re in.  But around here, these procedures will average - for privately insured patients - somewhere around $20,000 and $60,000.

On some level, this is as it should be.  Stents are often used for diagnoses that don’t require something as aggressive as bypass surgery, which is a far more invasive procedure.  Stents generally serve a “less sick” population.  But it still amazes me that when we talk about the relative performance of one service over another to treat illness in health care, we rarely talk about the cost of either one.

And just to complicate matters a little more, if you were to ask the CDC about why the per capita mortality rate for heart disease in this country has dropped by 50% over the past twenty years, they would say that improved surgical techniques could take about 5% of the credit.  The lion’s share of the credit would go to advances in pharmacology (blood pressure meds and cholesterol lowering meds - like statins), and a huge drop in smoking.

This is why we need to make the collection and distribution of health care cost and quality data a national priority.  We will never improve quality and reduce costs if we play this game one study at a time.  Back when she was running for President, Democratic candidate Hillary Clinton talked a lot about creating a National Best Practices Institute for Health Care.  I hope the folks that are left in that race pick up on this very fine idea and pursue it.

4 CommentsFollow responses through the RSS feed

  1. Barry Carol Says

    Charlie – As a patient who had both a CABG (1999) and then needed a stent (drug eluting) in 2005, I don’t think 12 month outcome data tells us a whole lot from a patient’s perspective. For patients who reasonably could have undergone either procedure at a given point in time, it would be more interesting to see outcomes data for five years and even ten years. From an insurer’s perspective, I think you should not only be interested in the mortality data, but also the cumulative cost of cardiac care. Assuming patients were prescribed similar drugs no matter which procedure they had, did those who received stents need to go back one or more times for additional stents and how did that impact the cumulative cost of care during the whole study period vs. those who received the CABG? I know one person who, after several procedures, now has seven stents. I wonder how common that is vs. how many people need a second CABG.

  2. Kittricc R. Says

    Charlie - I agree with you on your point about the collection and distrubution of quality and cost effectiveness data of health care providers. It should be a national priority, then you’ll see the adpation of CDHPs sky rocket. We don’t ask consumers who purchase televisions to buy them blind, we have information on brands, prices and technical specs for type of television we are looking. But yet we want health insurance consumers to adapt to products with very little informaton on where to get the best bang and quality for their buck.

  3. David Cohen Says

    Charlie-
    Stay tuned. My research group at the Mid America Heart Institute is in the process of performing precisely the economic analysis that you requested. This analysis was prospectively specified at the time the study was designed– it just takes a bit longer to complete because of the nature of the study database. So just be patient…

    Dave

    P.P.S. I also agree with Barry Caroll regarding the need for both long-term clinical and economic data to complete the picture– those will be coming as well.

    P.S. I miss the old digs in Boston, especially around baseball season. Andrea says “Hi” as well.

  4. Charlie Baker Says

    Dave — Can’t wait. Please let me know when you publish, and I’ll blab about that, too. The Devil Rays are turning out to be a tough out. Northing like the Orioles were when we were down on the Cape! Best to Andrea.

Post Your Comment

Comments will be reviewed before posting. Harvard Pilgrim reserves the right not to post comments it deems inappropriate, including those that use profanity, make personal attacks, or contain other inappropriate material. Entries containing signatures by someone other than the actual author will be removed.

Comments on this site are the sole responsibility of their writers and the accuracy and completeness of comment content is not guaranteed.